MIC Selected Publications
Christopher Basler’s Lab
1. Leung, D. W., K. C. Prins, D. M. Borek, M. Farahbakhsh, J. M. Tufariello, P. Ramanan, J. C. Nix, L. A. Helgeson, Z. Otwinowski, R. B. Honzatko, C. F. Basler, and G. K. Amarasinghe. 2010. Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35. Nat Struct Mol Biol 17:165-72.
2. Martinez, O., J. Johnson, B. Manicassamy, L. Rong, G. G. Olinger, L. E. Hensley, and C. F. Basler. 2010. Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cell Microbiol 12:148-57.
3. Prins, K. C., W. B. Cardenas, and C. F. Basler. 2009. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J Virol 83:3069-77.
4. Prins, K. C., S. Delpeut, D. W. Leung, O. Reynard, V. A. Volchkova, S. P. Reid, P. Ramanan, W. B. Cardenas, G. K. Amarasinghe, V. E. Volchkov, and C. F. Basler. 2010. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs. J Virol 84:3004-15.
5. Reid, S. P., C. Valmas, O. Martinez, F. M. Sanchez, and C. F. Basler. 2007. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. J Virol 81:13469-77.
6. Valmas, C., M. N. Grosch, M. Schumann, J. Olejnik, O. Martinez, S. M. Best, V. Krahling, C. F. Basler, and E. Muhlberger. 2010. Marburg virus evades interferon responses by a mechanism distinct from Ebola virus. PLoS Pathog 6(1):e1000745.
7. Ciancanelli, M. J., V. A. Volchkova, M. L. Shaw, V. E. Volchkov, and C. F. Basler. 2009. Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism. J Virol 83:7828-41.
8. Yu, X., T. Tsibane, P. A. McGraw, F. S. House, C. J. Keefer, M. D. Hicar, T. M. Tumpey, C. Pappas, L. A. Perrone, O. Martinez, J. Stevens, I. A. Wilson, P. V. Aguilar, E. L. Altschuler, C. F. Basler, and J. E. Crowe, Jr. 2008. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455:532-6.
Benjamin Chen’s Lab
Wolfgang Hübner, Gregory P. McNerney, Benjamin M. Dale, Ping Chen, Ronald E. Gordon, Frank Y. S. Chuang, Xiao-Dong Li, David M. Asmuth, Thomas Huser, and Benjamin K. Chen. Quantitative 3D Video Microscopy of HIV Transfer Across T cell Virological Synapses. Science. 323(5922):1743-7. (2009)
Ana Fernandez-Sesma’s Lab
Rodriguez-Madoz, J.R., Bernal-Rubio, D., Kaminski, D., Boyd, K. and A. Fernandez-Sesma. 2010. Dengue Virus Inhibits the Production of Type I Interferon in Primary Human Dendritic Cells. J Virol, 84(9), 4845-4850.
Thomas Moran’s Lab
1. Moltedo, B., C. B. Lopez, M. Pazos, M. I. Becker, T. Hermesh, and T. M. Moran. 2009. Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity. J Immunol 183:3569-3573.
2. Hermesh T MB, Moran TM, Lopez CB (2010) Anti-viral instruction of bone marrow leukocytes during respiratory virus infection. Cell Host Microbe in press.
3. Kraus Thomas, Rhoda S. Sperling, Stephanie M. Engel, Yungtai Lo, Lisa Kellerman, Tricia Singh, Martine Loubeau, Yongchao Ge, Jose Luis Garrido, Marta Rodríguez-García, Thomas M. Moran (2010) Peripheral Blood Cytokine Profiling during Pregnancy and Post-partum Periods American Journal of Reproductive Immunology.
Peter Palese’s Lab
1. Lowen, A., Palese, P. Transmission of influenza virus in temperate zones is predominantly by aerosol, in the tropics by contact: A hypothesis. PLoS Curr. Influenza. 2009 Aug 17:RRN1002
2. König, R., Stertz, S., Zhou, Y., Inoue, A., Hoffmann, H-Heinrich, Bhattacharyya, S., Alamares, J.G., Tscherne, D.M., Ortigoza, M.B., Liang, Y., Gao, Q., Andrews, S.E., Bandyopadhyay, S., De Jesus, P., Tu, B.P., Pache, L., Shih, C., Orth, A., Bonamy, G., Miraglia, L., Ideker, T., García-Sastre, A., Young, J.A., Palese, P., Shaw, M.L., Chanda, S.K. Human host factors required for influenza virus replication. Nature, 463:813-817, 2010.
3. Wang, T.T., Tan, G.S., Hai, R., Pica, N., Petersen, E., Moran, T.M., Palese, P. Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins. PLoS Pathog. 2010 Feb 26;6(2):e1000796.
Megan Shaw’s Lab
König, R., Stertz, S., Zhou, Y., Inoue, A., Hoffmann, H-Heinrich, Bhattacharyya, S., Alamares, J.G., Tscherne, D.M., Ortigoza, M.B., Liang, Y., Gao, Q., Andrews, S.E., Bandyopadhyay, S., De Jesus, P., Tu, B.P., Pache, L., Shih, C., Orth, A., Bonamy, G., Miraglia, L., Ideker, T., García-Sastre, A., Young, J.A., Palese, P., Shaw, M.L., Chanda, S.K. Human host factors required for influenza virus replication. Nature, 463:813-817, 2010.
Perez, J. T., A. M. Pham, M. H. Lorini, M. A. Chua, J. Steel, and B. R. tenOever. 2009. MicroRNA-mediated species-specific attenuation of influenza A virus. Nat Biotechnol 27:572-6.
Domenico Tortorella’s Lab
1. Noriega, V.M. and Tortorella, D. 2009 Human cytomegalovirus-encoded immune modulators partner to down-regulate MHC class I molecules. J Virol 83, 1359-67.
2. Oresic, K., Ng, C., and Tortorella, D. 2009 TRAM1 participates in HCMV US2- and US11-mediated dislocation of an ER membrane glycoprotein, J Biol Chem 284, 5905-14.
3.Ng, C., Oresic, K., and Tortorella, D. 2010 TRAM1 is an ER quality control factor that promotes dislocation of membrane substrates, Exp Cell Res, in press.
Thomas Weber’s Lab
Sachiko Hirosue, Karin Senn, Nathalie Clément, Mathieu Nonnenmacher, Laure Gigout, R. Michael Linden, and Thomas Weber. 2007. Effect of inhibition of dynein function and microtubule-altering drugs on AAV2 transduction Virology 367, 10-18